Forsta AP Fonden Sells 22,900 Shares of Xylem Inc. $XYL

Forsta AP Fonden cut its holdings in Xylem Inc. (NYSE:XYL) by 29.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 53,800 shares of the industrial products company’s stock after selling 22,900 shares during the period. Forsta AP Fonden’s holdings in Xylem were worth $7,326,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. State of Wyoming raised its position in Xylem by 10.4% in the third quarter. State of Wyoming now owns 756 shares of the industrial products company’s stock worth $112,000 after acquiring an additional 71 shares during the period. Orion Porfolio Solutions LLC raised its position in Xylem by 1.0% in the third quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock worth $1,151,000 after acquiring an additional 74 shares during the period. Journey Strategic Wealth LLC raised its position in Xylem by 1.5% in the third quarter. Journey Strategic Wealth LLC now owns 5,107 shares of the industrial products company’s stock worth $753,000 after acquiring an additional 77 shares during the period. Quest Investment Management LLC raised its position in Xylem by 1.0% in the third quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock worth $1,119,000 after acquiring an additional 77 shares during the period. Finally, Keel Point LLC raised its position in Xylem by 4.6% in the third quarter. Keel Point LLC now owns 1,784 shares of the industrial products company’s stock worth $263,000 after acquiring an additional 79 shares during the period. 87.96% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Xylem

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jerome A. Peribere bought 1,210 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the purchase, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.32% of the company’s stock.

Analysts Set New Price Targets

XYL has been the topic of several recent research reports. Stifel Nicolaus decreased their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Oppenheimer reduced their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. Jefferies Financial Group reissued a “hold” rating and issued a $130.00 price objective (down from $140.00) on shares of Xylem in a research note on Tuesday, March 31st. Mizuho set a $138.00 price objective on shares of Xylem in a research note on Wednesday, February 11th. Finally, Citigroup reduced their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $152.77.

Xylem Stock Performance

XYL opened at $108.38 on Tuesday. The stock has a market capitalization of $25.76 billion, a price-to-earnings ratio of 26.96, a PEG ratio of 1.56 and a beta of 1.05. The company has a fifty day moving average of $117.60 and a 200 day moving average of $129.31. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. The company had revenue of $2.13 billion during the quarter, compared to analysts’ expectations of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. Xylem’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the company posted $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, sell-side analysts forecast that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem declared that its Board of Directors has approved a share repurchase program on Wednesday, February 25th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the industrial products company to repurchase up to 4.8% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s leadership believes its stock is undervalued.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is presently 42.79%.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.